BANEET SAWHNEY: Open Payments
NPI 1447882253 · WOODBURY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,016 in 74 payments from 6 companies in 2025. Trend: 2023 $145 · 2024 $1,327 · 2025 $2,016
Food & beverage: $2,016
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $491 |
| Braeburn Inc. | 16 | $437 |
| Indivior Inc. | 18 | $363 |
| Otsuka America Pharmaceutical, Inc. | 13 | $349 |
| Alkermes, Inc. | 11 | $287 |
| ABBVIE INC. | 5 | $89 |
Products named: CAPLYTA, BRIXADI, SUBLOCADE, REXULTI, VIVITROL, VRAYLAR, ABILIFY ASIMTUFII, MAVYRET.
Industry payments across NJ — which companies pay providers there.
